|
Somatostatin analogue inhibits the mobility of prostate carcinoma cells: a new therapeutic method for advanced prostate carcinoma
|
29 November 2013 |
|
Treatment of unresectable skull base meningiomas with somatostatin analogs
|
29 November 2013 |
|
Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas
|
27 November 2013 |
|
Place of cabergoline in acromegaly: a meta-analysis
|
27 November 2013 |
|
Antitumor effects of somatostatin analogs in neuroendocrine tumors
|
25 November 2013 |
|
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide
|
25 November 2013 |
|
A randomized trial of somatostatin to regulate the VEGFs/VEGFRs in patients with gastric cancer
|
17 November 2013 |
|
Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells
|
15 November 2013 |
|
Autocrine proliferative effects of hGH are maintained in primary cultures of human mammary carcinoma cells
|
13 November 2013 |
|
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
|
10 November 2013 |